The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bispecific Antibody Therapeutic Market Research Report 2025
Synopsis
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
The global Bispecific Antibody Therapeutic market was valued at US$ 3266 million in 2023 and is anticipated to reach US$ 4147.6 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibody Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibody Therapeutic.
Report Scope
The Bispecific Antibody Therapeutic market size, estimations, and forecasts are provided in terms of output/shipments (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bispecific Antibody Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific Antibody Therapeutic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative-biolabs
PharmAbcine
Sorrento Therapeutics
Patheon
Segment by Type
Bearing An Fc Region
Lacking An Fc Region
Segment by Application
Osteology
Pulmonary
Respiratory Diseases
Oncology
Gene Therapy
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bispecific Antibody Therapeutic manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bispecific Antibody Therapeutic by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bispecific Antibody Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
The global Bispecific Antibody Therapeutic market was valued at US$ 3266 million in 2023 and is anticipated to reach US$ 4147.6 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibody Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibody Therapeutic.
Report Scope
The Bispecific Antibody Therapeutic market size, estimations, and forecasts are provided in terms of output/shipments (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bispecific Antibody Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific Antibody Therapeutic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative-biolabs
PharmAbcine
Sorrento Therapeutics
Patheon
Segment by Type
Bearing An Fc Region
Lacking An Fc Region
Segment by Application
Osteology
Pulmonary
Respiratory Diseases
Oncology
Gene Therapy
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bispecific Antibody Therapeutic manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bispecific Antibody Therapeutic by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bispecific Antibody Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Bispecific Antibody Therapeutic Market Overview
1.1 Product Definition
1.2 Bispecific Antibody Therapeutic Segment by Type
1.2.1 Global Bispecific Antibody Therapeutic Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Bearing An Fc Region
1.2.3 Lacking An Fc Region
1.3 Bispecific Antibody Therapeutic Segment by Application
1.3.1 Global Bispecific Antibody Therapeutic Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Osteology
1.3.3 Pulmonary
1.3.4 Respiratory Diseases
1.3.5 Oncology
1.3.6 Gene Therapy
1.4 Global Market Growth Prospects
1.4.1 Global Bispecific Antibody Therapeutic Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Bispecific Antibody Therapeutic Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Bispecific Antibody Therapeutic Production Estimates and Forecasts (2019-2030)
1.4.4 Global Bispecific Antibody Therapeutic Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Bispecific Antibody Therapeutic Production Market Share by Manufacturers (2019-2024)
2.2 Global Bispecific Antibody Therapeutic Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Bispecific Antibody Therapeutic, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Bispecific Antibody Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Bispecific Antibody Therapeutic Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Bispecific Antibody Therapeutic, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Bispecific Antibody Therapeutic, Product Offered and Application
2.8 Global Key Manufacturers of Bispecific Antibody Therapeutic, Date of Enter into This Industry
2.9 Bispecific Antibody Therapeutic Market Competitive Situation and Trends
2.9.1 Bispecific Antibody Therapeutic Market Concentration Rate
2.9.2 Global 5 and 10 Largest Bispecific Antibody Therapeutic Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Bispecific Antibody Therapeutic Production by Region
3.1 Global Bispecific Antibody Therapeutic Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Bispecific Antibody Therapeutic Production Value by Region (2019-2030)
3.2.1 Global Bispecific Antibody Therapeutic Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Bispecific Antibody Therapeutic by Region (2025-2030)
3.3 Global Bispecific Antibody Therapeutic Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Bispecific Antibody Therapeutic Production by Region (2019-2030)
3.4.1 Global Bispecific Antibody Therapeutic Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Bispecific Antibody Therapeutic by Region (2025-2030)
3.5 Global Bispecific Antibody Therapeutic Market Price Analysis by Region (2019-2024)
3.6 Global Bispecific Antibody Therapeutic Production and Value, Year-over-Year Growth
3.6.1 North America Bispecific Antibody Therapeutic Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Bispecific Antibody Therapeutic Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Bispecific Antibody Therapeutic Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Bispecific Antibody Therapeutic Production Value Estimates and Forecasts (2019-2030)
4 Bispecific Antibody Therapeutic Consumption by Region
4.1 Global Bispecific Antibody Therapeutic Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Bispecific Antibody Therapeutic Consumption by Region (2019-2030)
4.2.1 Global Bispecific Antibody Therapeutic Consumption by Region (2019-2024)
4.2.2 Global Bispecific Antibody Therapeutic Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Bispecific Antibody Therapeutic Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Bispecific Antibody Therapeutic Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Bispecific Antibody Therapeutic Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Bispecific Antibody Therapeutic Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Bispecific Antibody Therapeutic Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Bispecific Antibody Therapeutic Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Bispecific Antibody Therapeutic Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Bispecific Antibody Therapeutic Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Bispecific Antibody Therapeutic Production by Type (2019-2030)
5.1.1 Global Bispecific Antibody Therapeutic Production by Type (2019-2024)
5.1.2 Global Bispecific Antibody Therapeutic Production by Type (2025-2030)
5.1.3 Global Bispecific Antibody Therapeutic Production Market Share by Type (2019-2030)
5.2 Global Bispecific Antibody Therapeutic Production Value by Type (2019-2030)
5.2.1 Global Bispecific Antibody Therapeutic Production Value by Type (2019-2024)
5.2.2 Global Bispecific Antibody Therapeutic Production Value by Type (2025-2030)
5.2.3 Global Bispecific Antibody Therapeutic Production Value Market Share by Type (2019-2030)
5.3 Global Bispecific Antibody Therapeutic Price by Type (2019-2030)
6 Segment by Application
6.1 Global Bispecific Antibody Therapeutic Production by Application (2019-2030)
6.1.1 Global Bispecific Antibody Therapeutic Production by Application (2019-2024)
6.1.2 Global Bispecific Antibody Therapeutic Production by Application (2025-2030)
6.1.3 Global Bispecific Antibody Therapeutic Production Market Share by Application (2019-2030)
6.2 Global Bispecific Antibody Therapeutic Production Value by Application (2019-2030)
6.2.1 Global Bispecific Antibody Therapeutic Production Value by Application (2019-2024)
6.2.2 Global Bispecific Antibody Therapeutic Production Value by Application (2025-2030)
6.2.3 Global Bispecific Antibody Therapeutic Production Value Market Share by Application (2019-2030)
6.3 Global Bispecific Antibody Therapeutic Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Creative-biolabs
7.1.1 Creative-biolabs Bispecific Antibody Therapeutic Corporation Information
7.1.2 Creative-biolabs Bispecific Antibody Therapeutic Product Portfolio
7.1.3 Creative-biolabs Bispecific Antibody Therapeutic Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Creative-biolabs Main Business and Markets Served
7.1.5 Creative-biolabs Recent Developments/Updates
7.2 PharmAbcine
7.2.1 PharmAbcine Bispecific Antibody Therapeutic Corporation Information
7.2.2 PharmAbcine Bispecific Antibody Therapeutic Product Portfolio
7.2.3 PharmAbcine Bispecific Antibody Therapeutic Production, Value, Price and Gross Margin (2019-2024)
7.2.4 PharmAbcine Main Business and Markets Served
7.2.5 PharmAbcine Recent Developments/Updates
7.3 Sorrento Therapeutics
7.3.1 Sorrento Therapeutics Bispecific Antibody Therapeutic Corporation Information
7.3.2 Sorrento Therapeutics Bispecific Antibody Therapeutic Product Portfolio
7.3.3 Sorrento Therapeutics Bispecific Antibody Therapeutic Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Sorrento Therapeutics Main Business and Markets Served
7.3.5 Sorrento Therapeutics Recent Developments/Updates
7.4 Patheon
7.4.1 Patheon Bispecific Antibody Therapeutic Corporation Information
7.4.2 Patheon Bispecific Antibody Therapeutic Product Portfolio
7.4.3 Patheon Bispecific Antibody Therapeutic Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Patheon Main Business and Markets Served
7.4.5 Patheon Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Bispecific Antibody Therapeutic Industry Chain Analysis
8.2 Bispecific Antibody Therapeutic Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Bispecific Antibody Therapeutic Production Mode & Process
8.4 Bispecific Antibody Therapeutic Sales and Marketing
8.4.1 Bispecific Antibody Therapeutic Sales Channels
8.4.2 Bispecific Antibody Therapeutic Distributors
8.5 Bispecific Antibody Therapeutic Customers
9 Bispecific Antibody Therapeutic Market Dynamics
9.1 Bispecific Antibody Therapeutic Industry Trends
9.2 Bispecific Antibody Therapeutic Market Drivers
9.3 Bispecific Antibody Therapeutic Market Challenges
9.4 Bispecific Antibody Therapeutic Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
